X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3125) 3125
Publication (362) 362
Book Review (287) 287
Magazine Article (8) 8
Book Chapter (6) 6
Book / eBook (5) 5
Conference Proceeding (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (2915) 2915
male (1972) 1972
animals (1837) 1837
dronabinol - pharmacology (1729) 1729
humans (1504) 1504
female (970) 970
rats (968) 968
dronabinol - administration & dosage (963) 963
pharmacology & pharmacy (740) 740
adult (692) 692
dose-response relationship, drug (682) 682
neurosciences (621) 621
mice (603) 603
dronabinol - analogs & derivatives (576) 576
cannabis (571) 571
marijuana (565) 565
cannabinoids (557) 557
time factors (478) 478
tetrahydrocannabinol (443) 443
psychiatry (388) 388
dronabinol - therapeutic use (376) 376
delta-9-tetrahydrocannabinol (351) 351
thc (319) 319
middle aged (316) 316
double-blind method (284) 284
behavior, animal - drug effects (280) 280
dronabinol - adverse effects (278) 278
cannabinoids - pharmacology (272) 272
rats, sprague-dawley (271) 271
delta-tetrahydrocannabinol (262) 262
administration, oral (261) 261
dronabinol - blood (256) 256
cannabis - pharmacology (254) 254
dronabinol (251) 251
article (238) 238
pyrazoles - pharmacology (236) 236
piperidines - pharmacology (235) 235
cannabinoid (228) 228
adolescent (226) 226
motor activity - drug effects (224) 224
young adult (223) 223
brain - drug effects (213) 213
cannabidiol (197) 197
dronabinol - metabolism (197) 197
brain (195) 195
abridged index medicus (191) 191
clinical neurology (186) 186
drug tolerance (183) 183
drug interactions (177) 177
analysis (172) 172
brain - metabolism (172) 172
heart rate - drug effects (170) 170
rats, wistar (162) 162
dronabinol - pharmacokinetics (161) 161
dronabinol - toxicity (159) 159
mental disorders (154) 154
endocannabinoids (152) 152
receptor, cannabinoid, cb1 - metabolism (147) 147
endocannabinoid system (143) 143
dronabinol - analysis (142) 142
injections, intravenous (138) 138
pharmacology (138) 138
drugs (134) 134
drug combinations (133) 133
anandamide (130) 130
receptor, cannabinoid, cb1 - agonists (129) 129
receptors, cannabinoid (126) 126
cannabidiol - pharmacology (125) 125
mice, inbred c57bl (125) 125
rat (122) 122
treatment outcome (122) 122
aged (121) 121
disease models, animal (121) 121
receptor (119) 119
analysis of variance (118) 118
phytotherapy (118) 118
psychotropic drugs - pharmacology (118) 118
receptor, cannabinoid, cb1 - antagonists & inhibitors (118) 118
cross-over studies (117) 117
pain (116) 116
drug abuse (115) 115
research (114) 114
substance abuse (114) 114
pharmacology/toxicology (113) 113
rats, inbred strains (112) 112
smoking (112) 112
biomedicine (111) 111
injections, intraperitoneal (109) 109
dronabinol - urine (108) 108
psychomotor performance - drug effects (108) 108
blood pressure - drug effects (103) 103
hallucinogens - pharmacology (103) 103
body temperature - drug effects (102) 102
pregnancy (99) 99
cannabinoids - therapeutic use (98) 98
cannabinoids - administration & dosage (97) 97
toxicology (97) 97
neurology (95) 95
placebos (95) 95
arachidonic acids - pharmacology (94) 94
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3099) 3099
German (17) 17
French (6) 6
Russian (6) 6
Spanish (4) 4
Norwegian (2) 2
Chinese (1) 1
Danish (1) 1
Dutch (1) 1
Italian (1) 1
Japanese (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Pharmaceutical Sciences, ISSN 0928-0987, 11/2017, Volume 109, pp. 21 - 30
The lipophilic phytocannabinoids cannabidiol (CBD) and Δ -tetrahydrocannabinol (THC) show therapeutic efficacy in various medical conditions. Both molecules... 
Cannabinoids | Oral bioavailability | Piperine | SNEDDS | First pass effect | RESVERATROL | CURCUMIN | P-GLYCOPROTEIN | UDP-GLUCURONOSYLTRANSFERASE | IN-VITRO | LIPID-BASED FORMULATIONS | METABOLISM | PHARMACOKINETICS | ENZYMES | PHARMACOLOGY & PHARMACY | Polyunsaturated Alkamides - chemistry | Emulsions | Stilbenes - administration & dosage | Cannabidiol - administration & dosage | Excipients - pharmacokinetics | Nanoparticles - chemistry | Rats, Wistar | Alkaloids - pharmacokinetics | Curcumin - chemistry | Biological Availability | Male | Stilbenes - chemistry | Benzodioxoles - administration & dosage | Curcumin - administration & dosage | Drug Delivery Systems | Lipids - chemistry | Excipients - chemistry | Benzodioxoles - pharmacokinetics | Piperidines - pharmacokinetics | Benzodioxoles - chemistry | Cannabidiol - pharmacokinetics | Cannabidiol - chemistry | Piperidines - administration & dosage | Piperidines - chemistry | Gastrointestinal Absorption | Administration, Oral | Curcumin - pharmacokinetics | Lipids - administration & dosage | Dronabinol - pharmacokinetics | Excipients - administration & dosage | Polyunsaturated Alkamides - administration & dosage | Animals | Lipids - pharmacokinetics | Stilbenes - pharmacokinetics | Alkaloids - administration & dosage | Nanoparticles - administration & dosage | Polyunsaturated Alkamides - pharmacokinetics | Dronabinol - administration & dosage | Dronabinol - chemistry | Alkaloids - chemistry | Index Medicus
Journal Article
Journal Article
Journal of Psychopharmacology, ISSN 0269-8811, 09/2008, Volume 22, Issue 7, pp. 707 - 716
This randomised, double-blind, placebo-controlled, cross-over study was designed to identify which pharmacodynamic parameters most accurately quantify the... 
Human | Volcano® vaporizer | Cannabis | Pharmacodynamics | Healthy volunteers | CB1 receptor | Cannabinoid | Pharmacokinetics | THC | LOCALIZATION | PSYCHIATRY | cannabinoid | pharmacodynamics | PERFORMANCE | healthy volunteers | cannabis | MARIHUANA | NEUROSCIENCES | CLINICAL NEUROLOGY | MARIJUANA | PLASMA-CONCENTRATIONS | DELTA-9-TETRAHYDROCANNABINOL | (-)DELTA9-TRANS-TETRAHYDROCANNABINOL | CANNABIS-SATIVA | pharmacokinetics | PHARMACOLOGY & PHARMACY | human | BRAIN | Volcano (R) vaporizer | CB1 RECEPTORS | Hallucinogens - pharmacokinetics | Hallucinogens - administration & dosage | Hallucinogens - pharmacology | Double-Blind Method | Humans | Administration, Inhalation | Male | Postural Balance - drug effects | Psychomotor Performance - drug effects | Dronabinol - pharmacokinetics | Perception - drug effects | Cross-Over Studies | Young Adult | Heart Rate - drug effects | Electroencephalography - drug effects | Pupil - drug effects | Aerosols | Central Nervous System - drug effects | Adult | Pursuit, Smooth - drug effects | Blood Pressure - drug effects | Dronabinol - administration & dosage | Dronabinol - pharmacology | Saccades - drug effects | Complications and side effects | Usage | Nebulizers and vaporizers | Dosage and administration | Research | Tetrahydrocannabinol | Drugs | Clinical trials | Physiology | Psychopharmacology | Index Medicus
Journal Article
Drug and Alcohol Dependence, ISSN 0376-8716, 06/2018, Volume 187, pp. 254 - 260
Journal Article
Psychopharmacology, ISSN 0033-3158, 8/2018, Volume 235, Issue 8, pp. 2357 - 2365
Cannabinoid receptor agonists such as delta-9-tetrahydrocannabinol (Δ9-THC) enhance the antinociceptive potency of mu opioid receptor agonists such as... 
Drug self-administration | Neurosciences | Cannabinoids | Biomedicine | Drug mixtures | Opioids | Pharmacology/Toxicology | Psychiatry | Choice procedures | Rhesus monkeys | UNITED-STATES | CHRONIC PAIN | PSYCHIATRY | DRUG CHOICE | DELTA-9-TETRAHYDROCANNABINOL TREATMENT | COCAINE | NEUROSCIENCES | HEROIN | PHARMACOLOGY & PHARMACY | REMIFENTANIL | FOOD CHOICE | OPIOID RECEPTOR AGONISTS | Eating - psychology | Choice Behavior - drug effects | Cannabinoids - administration & dosage | Reinforcement (Psychology) | Male | Macaca mulatta | Reaction Time - physiology | Cannabinoid Receptor Agonists - administration & dosage | Eating - physiology | Dose-Response Relationship, Drug | Eating - drug effects | Self Administration | Animals | Analgesics, Opioid - administration & dosage | Reaction Time - drug effects | Choice Behavior - physiology | Female | Dronabinol - administration & dosage | Cyclohexanols - administration & dosage | Pharmaceutical research | Receptors | Research | Tetrahydrocannabinol | Drug synergism | Drug abuse | Pain perception | Intravenous administration | Sucrose | Narcotics | Opioid receptors (type mu) | Morphine | Monkeys | Remifentanil | Infusion | Pain | Food availability | Drug dosages | Heroin | Sugars | Food | Index Medicus | cannabinoids | choice procedures | drug mixtures | rhesus monkeys | opioids | drug self-administration
Journal Article